Who is sponsoring NCT00984503?

NCT00984503 is sponsored by Renovo.

What condition does NCT00984503 study?

NCT00984503 studies Cicatrix, Wound Healing.

What drugs are being tested in NCT00984503?

Interventions: Avotermin, Placebo, Avotermin, Placebo.

What is the status of NCT00984503?

NCT00984503 is currently COMPLETED.

Last reviewed 2009-09-24 · How we verify

A Single-site, Randomised, Double-blind, Phase II Trial to Investigate the Safety, Toleration, Systemic Exposure, Accelerated Healing and Anti-scarring Potential of Juvista in Split Skin Graft Donor Sites in Male Subjects Aged 18-85 Years

NCT00984503 Phase 2 COMPLETED

The purpose of this study is to investigate the accelerated-healing potential of injection or injection plus topical application of Juvista to minor split skin grafts (SSG).

Details

Lead sponsor	Renovo
Phase	Phase 2
Status	COMPLETED
Enrolment	102
Start date	2003-10
Completion	2006-01

Conditions

Cicatrix
Wound Healing

Interventions

Avotermin
Placebo
Avotermin
Placebo

Primary outcomes

To assess the accelerated-healing potential of injection or injection plus topical application of Juvista in a male population undergoing minor split skin grafts (SSG) — Up to 12 months

Countries

United Kingdom